13.8 Respiratory Anatomy, Ventilation Mechanics & Pulmonary Surfactant

13.8 Respiratory Anatomy, Ventilation Mechanics & Pulmonary Surfactant

Gas exchange couples mechanical ventilation of the pulmonary alveoli with passive diffusion across the blood-gas barrier and chemical buffering within circulating red blood cells. Mastery requires understanding the biophysical laws of gases and the enzymatic equilibria governing plasma bicarbonate.

---

Anatomical Organization & Defense Mechanisms

The respiratory tract is anatomically divided into the upper and lower respiratory tracts, and functionally divided into two distinct zones:

• Conducting Zone: Transports, warms, filters, and humidifies inspired air without participating in gas exchange. Extends from the nasal cavity through the pharynx, larynx, trachea, primary/secondary/tertiary bronchi, and bronchioles down to the terminal bronchioles. It contains approximately 150 mL of anatomical dead space ($V_D$).
  • Histology: Lined by pseudostratified ciliated columnar epithelium with mucus-secreting goblet cells. The coordinated rhythmic beating of cilia propels inhaled particulates trapped in mucus upward toward the pharynx to be swallowed or expectorated—a defense system known as the mucociliary escalator. In cystic fibrosis, defective CFTR chloride channels cause thick, dehydrated mucus that paralyzes the escalator, causing chronic infections.
  • Airway Smooth Muscle: The walls of bronchioles lack cartilage but possess prominent smooth muscle innervated by the autonomic nervous system: sympathetic stimulation (circulating epinephrine acting on $\beta_2$ adrenergic receptors) triggers bronchodilation, while parasympathetic stimulation (vagus nerve acting on $M_3$ muscarinic receptors) triggers bronchoconstriction and mucus secretion.
• Respiratory Zone: The microscopic site of gas exchange, comprising respiratory bronchioles, alveolar ducts, and approximately 300 to 500 million alveoli, providing a vast surface area (~70-100 square meters) for diffusion.
  • Type I Pneumocytes (95% of alveolar surface): Extremely thin, squamous epithelial cells (0.1-0.2 micrometers thick) forming the structural diffusion barrier.
  • Type II Pneumocytes (5% of alveolar surface): Cuboidal secretory cells packed with lamellar bodies that synthesize and secrete pulmonary surfactant. They also function as stem cell progenitors that divide and differentiate to regenerate Type I pneumocytes following alveolar injury.
  • Alveolar Macrophages (Dust Cells): Phagocytose inhaled particulate matter, pathogens, and debris that escape upper airway defenses.

---

Mechanics of Pulmonary Ventilation: Boyle's Law & Pressure Gradients

Pulmonary ventilation operates via negative pressure breathing, governed by Boyle's Law ($P_1 V_1 = P_2 V_2$ at constant temperature), which states that the pressure of a given mass of gas is inversely proportional to its volume:

1. Inhalation (An Active Muscular Process)

• Primary Inspiratory Muscles: The dome-shaped diaphragm (innervated by the phrenic nerves originating from cervical roots $C3, C4, C5$: "C3, 4, 5 keep the diaphragm alive") and the external intercostal muscles (innervated by intercostal nerves).
• Mechanism: Contraction of the diaphragm causes it to flatten downward, expanding the vertical thoracic dimension. Contraction of the external intercostals pulls the ribs upward and outward like a bucket-handle, expanding the anteroposterior and transverse thoracic diameters.
• Pressure Changes: Expansion of the closed thoracic cavity increases intrapleural volume, causing intrapleural pressure ($P_{ip}$) to drop from its resting value of -5 cm H2O down to approximately -8 cm H2O.
• Transpulmonary Pressure ($P_L = P_{alv} - P_{ip}$): The difference between alveolar pressure and intrapleural pressure represents the outward distending pressure holding the lungs open. As $P_{ip}$ becomes more negative, transpulmonary pressure increases, pulling the elastic lungs outward.
• Airflow: Expansion of alveolar volume causes alveolar pressure ($P_{alv}$) to drop below atmospheric pressure (0 cm H2O), dropping to -1 cm H2O. Atmospheric air rushes down this inward pressure gradient through the conducting airways until $P_{alv}$ equilibrates with atmospheric pressure (0 cm H2O), terminating the tidal breath.

2. Exhalation (Passive vs. Forced Active)

• Quiet Exhalation (Passive Elastic Recoil): Requires no muscle contraction. The diaphragm and external intercostals simply relax. The stored potential energy in the stretched elastic fibers of the lung parenchyma and the inward surface tension of the alveoli cause the lungs and chest wall to passively recoil to their resting volumes. As thoracic volume decreases, $P_{ip}$ rises back to -5 cm H2O, compressing alveolar gas so that $P_{alv}$ rises to +1 cm H2O, driving air out of the lungs down its pressure gradient.
• Forced Active Exhalation: Occurs during heavy exercise, coughing, or obstructive pulmonary disease. It recruitment active muscular contraction:
  • Internal Intercostal Muscles: Pull the ribs downward and inward, compressing the thoracic cage.
  • Abdominal Wall Muscles (Rectus abdominis, External/Internal obliques, Transversus abdominis): Contract forcefully, compressing abdominal viscera and thrusting the relaxed diaphragm upward into the thoracic cavity. Alveolar pressure spikes to +20 to +30 cm H2O, forcefully expelling air.

---

Pulmonary Surfactant & The Law of Laplace

The thin liquid film lining the curved inner surface of spherical alveoli creates an air-water interface. Water molecules exert strong intermolecular hydrogen bonding forces, producing surface tension ($T$) that tends to collapse the alveolus.

The Law of Laplace

For a spherical structure with a single air-liquid interface, the collapsing inward pressure ($P$) is defined by the Law of Laplace:

$$P = \frac{2T}{r}$$

(where $P$ is collapsing pressure, $T$ is surface tension, and $r$ is alveolar radius).

• The Biophysical Problem Without Surfactant: If surface tension ($T$) were constant, smaller alveoli ($r_{small} < r_{large}$) would experience a substantially higher collapsing pressure than larger alveoli. By Pascal's principle, air would flow down the pressure gradient from high pressure (small alveoli) into low pressure (large alveoli), causing widespread collapse of small alveoli (atelectasis) and hyperinflation of large alveoli.

The Surfactant Solution

Type II pneumocytes synthesize and secrete pulmonary surfactant, an amphipathic lipoprotein complex composed of 90% lipids (predominantly dipalmitoylphosphatidylcholine [DPPC]) and 10% proteins (surfactant proteins SP-A, SP-B, SP-C, SP-D):

• Mechanism: The hydrophobic fatty acyl tails of DPPC project into the alveolar air space while its hydrophilic polar head groups orient within the water layer, physically disrupting intermolecular hydrogen bonding between water molecules. This dramatically reduces surface tension ($T$) from 70 dynes/cm (pure water) down to nearly zero (<5 dynes/cm) at low lung volumes.
• Radius-Dependent Regulation: As an alveolus shrinks during expiration, surfactant molecules become packed more tightly together at the surface, reducing surface tension ($T$) to a far greater extent than in larger alveoli. By reducing $T$ proportionally with $r$, the ratio $2T/r$ remains nearly equal across all alveolar sizes, equalizing collapsing pressure, preventing atelectasis, and markedly increasing pulmonary compliance (reducing the work of breathing).
• Clinical Correlate: Infant Respiratory Distress Syndrome (IRDS): Premature infants born before 32-34 weeks of gestation lack mature Type II pneumocytes and cannot synthesize sufficient DPPC. High surface tension causes massive atelectasis, hypoxemia, and respiratory failure, requiring treatment with exogenous bovine/porcine surfactant and positive airway pressure (CPAP).

---

Quiet versus Forced Breathing

Quiet expiration is the only phase of the normal respiratory cycle that requires no muscular work, which is why obstructive disease impairs expiration first.